2021
DOI: 10.1536/ihj.20-238
|View full text |Cite
|
Sign up to set email alerts
|

<i>BIRC5</i>, <i>GAJ5,</i> and lncRNA NPHP3-AS1 Are Correlated with the Development of Atrial Fibrillation-Valvular Heart Disease

Abstract: The aim of this study was to explore the pivotal genes or lncRNAs involved in the progression of atrial fibrillation (AF)-valvular heart disease (VHD). The mRNA profiling GSE113013 was obtained from the Gene Expression Omnibus database. The identification of differentially expressed genes (DEGs) and differentially expressed long non-coding RNAs (DElncRNAs) was performed. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were carried out for DEGs. Then, the construction of th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…Still, when T cell reactivity is sustained, these reparative efforts often result in adverse remodeling that, when chronic, can progress to HF. Birc5 encodes survivin, a known apoptosis inhibitor that regulates T cell responses identified as a critical gene in the progression of atrial fibrillation [ 39 ]. Knockdown or pharmacological inhibition of Birc5 in T cells attenuates acute allograft rejection survival of cardiac allografts after murine heterotopic heart transplantation by inducing apoptosis [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Still, when T cell reactivity is sustained, these reparative efforts often result in adverse remodeling that, when chronic, can progress to HF. Birc5 encodes survivin, a known apoptosis inhibitor that regulates T cell responses identified as a critical gene in the progression of atrial fibrillation [ 39 ]. Knockdown or pharmacological inhibition of Birc5 in T cells attenuates acute allograft rejection survival of cardiac allografts after murine heterotopic heart transplantation by inducing apoptosis [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…LncRNAs are demonstrated to have biological functions in the pathological process of cardiovascular diseases and are differentially expressed in AF patients, such as lncRNA MIAT, lncRNA LINC00472, and lncRNA NPHP3-AS1. 12,22,23 It has been reported that lncRNA GAS5 is a potential biomarker for the diagnosis and prognosis of AF and can be used for the prognosis of AF progression and recurrence. 6 LncRNA LINC00472 is lowly expressed in AF patients; it reduces the expression of JP2 and RyR2 through miR-24 and participates in the pathogenesis of AF.…”
Section: Discussionmentioning
confidence: 99%
“…Existing evidences have reported that HNF4G [39], SLC15A1 [40], CXCL5 [41] and MALAT1 [42] promotes obesity, but these genes might be novel target for GDM. NPHP3-AS1 [43], LTA (lymphotoxin alpha) [44], CXCL5 [45] and MALAT1 [46] are found to be expressed in cardiovascular diseases, but these genes might be novel targets for GDM. A recent study demonstrated that XIST (X inactive specific transcript) [47] and MALAT1 [48] serves a crucial role in GDM progression.…”
Section: Discussionmentioning
confidence: 99%